Literature DB >> 15980114

Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma.

M E Baser, T Y Poussaint.   

Abstract

Chromosome 22q loss of heterozygosity (LOH) is the most common allelic loss in benign meningioma and is thought to be the earliest initiating event in meningioma formation. We used published data and logistic regression to evaluate the association of 22q LOH with age at diagnosis in 318 transitional, fibroblastic, and meningothelial meningiomas. After adjustment for anatomical location, the odds ratio of 22q LOH per year of age was >1 in each histological type of meningioma, and was significantly >1 in transitional and fibroblastic meningioma. This finding is compatible with involvement of the neurofibromatosis 2 tumour suppressor gene, NF2, on chromosome 22q in the high incidence of benign meningioma in the elderly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15980114      PMCID: PMC2563234          DOI: 10.1136/jmg.2005.035162

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  33 in total

1.  NF2 status of meningiomas is associated with tumour localization and histology.

Authors:  J Kros; K de Greve; A van Tilborg; W Hop; H Pieterman; C Avezaat; R Lekanne Dit Deprez; E Zwarthoff
Journal:  J Pathol       Date:  2001-07       Impact factor: 7.996

2.  Molecular genetic analysis of chromosome 22 in 81 cases of meningioma.

Authors:  J P Dumanski; G A Rouleau; M Nordenskjöld; V P Collins
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

3.  Age-associated loss of heterozygosity of tumor suppressor genes in the gastric mucosa of humans.

Authors:  Lathika Moragoda; Richard Jaszewski; Prasad Kulkarni; Adhip P N Majumdar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-06       Impact factor: 4.052

4.  Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas.

Authors:  R H Lekanne Deprez; P H Riegman; E van Drunen; U L Warringa; N A Groen; S Z Stefanko; J W Koper; C J Avezaat; P G Mulder; E C Zwarthoff
Journal:  J Neuropathol Exp Neurol       Date:  1995-03       Impact factor: 3.685

5.  Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.

Authors:  M H Ruttledge; J Sarrazin; S Rangaratnam; C M Phelan; E Twist; P Merel; O Delattre; G Thomas; M Nordenskjöld; V P Collins
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

6.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

Authors:  J A Trofatter; M M MacCollin; J L Rutter; J R Murrell; M P Duyao; D M Parry; R Eldridge; N Kley; A G Menon; K Pulaski
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

7.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.

Authors:  G A Rouleau; P Merel; M Lutchman; M Sanson; J Zucman; C Marineau; K Hoang-Xuan; S Demczuk; C Desmaze; B Plougastel
Journal:  Nature       Date:  1993-06-10       Impact factor: 49.962

8.  Characterization of a new member of the human beta-adaptin gene family from chromosome 22q12, a candidate meningioma gene.

Authors:  M Peyrard; I Fransson; Y G Xie; F Y Han; M H Ruttledge; S Swahn; J E Collins; I Dunham; V P Collins; J P Dumanski
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

9.  Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.

Authors:  J Sainz; D P Huynh; K Figueroa; N K Ragge; M E Baser; S M Pulst
Journal:  Hum Mol Genet       Date:  1994-06       Impact factor: 6.150

10.  Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.

Authors:  L Papi; L R De Vitis; F Vitelli; F Ammannati; P Mennonna; E Montali; U Bigozzi
Journal:  Hum Genet       Date:  1995-03       Impact factor: 4.132

View more
  3 in total

1.  Early malignant transformation of a petroclival meningothelial meningioma.

Authors:  Shigeo Ohba; Kazunari Yoshida; Yuichi Hirose; Eiji Ikeda; Takeshi Kawase
Journal:  Neurosurg Rev       Date:  2009-06-17       Impact factor: 3.042

2.  Loss of heterozygosity of the p53 gene and deregulated expression of its mRNA and protein in human brain tumors.

Authors:  K Rohini; J Mathivanan; P D Antony Herold Prabhu; D K Subbakrishna; M L Gope; B A Chandramouli; S Sampath; B Anandh; R Gope
Journal:  Mol Cell Biochem       Date:  2006-12-16       Impact factor: 3.842

3.  Intracranial meningioma with leptomeningeal dissemination : retrospective study with review of the literature.

Authors:  Ki-Su Park; Ki-Hong Kim; Seong-Hyun Park; Jeong-Hyun Hwang; Dong-Hyun Lee
Journal:  J Korean Neurosurg Soc       Date:  2015-04-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.